MSD
Pembrolizumab/Olaparib
Biodrugs/ Drugs
Cancer
Pembro plus Olaparib Vs Abiraterone Acetate or Enzalutamide in participants w/metastatic castration-resistant prostate cancer who are unselected for homologous recomb repair defects & have failed prior treatm. w/one next-generation hormonal agent and chem
3Phase III in Spain,
2Phase II,
1Phase I